Bain Capital said its decision to buy Mitsubishi Tanabe is due to the “strong growth potential” of Japan’s healthcare ...
Keith Largay joins Bain Capital from JLL, where he spent 14 years and most recently served as co-head of its Chicago office.
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
Speaking with Barron’s Advisor, Skinner, who founded the firm in 2019 with longtime partners Alan Zafran, Eric Harrison, Jeff ...
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...
Following rumblings of a private equity bidding war late last year, Bain Capital has emer | Bain Capital is laying out 510 ...
Mitsubishi UFJ Morgan Stanley Securities and BofA Securities are serving as financial advisors, and Morrison Foerster, Mori, Hamada & Matsumoto and Ropes & Gray are serving as legal advisors to Bain ...
The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a bid to focus on its key businesses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback